Finance

Lists
Why is ALXO down 6,15%?
Dive Deeper
ALXO:NASDAQ
ALX Oncology Holdings Inc
1,22 $
-6,15%
(-0,080) 1D
1,24 $
+1,64% (+0,020)
After hours
Closed: 2 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALXO...
Open
1,30 $
High
1,38 $
Low
1,20 $
Mkt. cap
168,70 մլն
Avg. vol.
996,14 հզր
Volume
2,26 մլն
52-wk high
2,66 $
52-wk low
1,05 $
EPS
-1,14 $
Beta
0,47
Shares outstanding
138,28 մլն
No. of employees
48
Open
1,30 $
High
1,38 $
Low
1,20 $
Mkt. cap
168,70 մլն
Avg. vol.
996,14 հզր
Volume
2,26 մլն
52-wk high
2,66 $
52-wk low
1,05 $
EPS
-1,14 $
Beta
0,47
Shares outstanding
138,28 մլն
No. of employees
48
News stories
From web sources and news partners
About ALX Oncology Holdings Inc
CEO-
Employees48
Founded2015
HeadquartersSouth San Francisco, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websitealxoncology.com
Analyst ratings
Based on 4 analysts giving stock ratings to ALXO in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ALXO in the last 3 months.
Highest
Current 1,22 $
5,00 $ (+309,84%)
Average
4,33 $ (+254,92%)
Lowest
4,00 $ (+227,87%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
4,00 $
+227,9%
10/01/2026
Derek Archila
Wells Fargo
Buy
Maintained
5,00 $
+309,8%
09/21/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
4,00 $
+227,9%
08/17/2026
Sam Slutsky
LifeSci Capital
Hold
Maintained
-
-
08/06/2026
Michael Yee
UBS
Buy
Maintained
6,00 $
+391,8%
05/12/2026
Last report
06 օգս, 2026 թ.
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,11 $ / -0,16 $
+32,46%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
17,44 մլն
17,64 մլն
13,61 մլն
13,14 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,09 մլն
5,38 մլն
5,36 մլն
5,13 մլն
Operating expense
22,53 մլն
23,02 մլն
18,97 մլն
18,27 մլն
Total operating expenses
22,53 մլն
23,02 մլն
18,97 մլն
18,27 մլն
Operating income
-22,53 մլն
-23,02 մլն
-18,97 մլն
-18,27 մլն
Other non operating income
-
-
188,00 հզր
-
EBT including unusual items
-22,14 մլն
-22,85 մլն
-17,93 մլն
-17,97 մլն
EBT excluding unusual items
-22,14 մլն
-22,85 մլն
-17,93 մլն
-17,06 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-22,14 մլն
-22,85 մլն
-17,93 մլն
-17,97 մլն
Net profit margin
-
-
-
-
Earnings per share
-
-0,37
-0,15
-0,11
Interest and investment income
802,00 հզր
573,00 հզր
1,18 մլն
1,51 մլն
Interest expense
-408,00 հզր
-383,00 հզր
-331,00 հզր
-285,00 հզր
Net interest expenses
394,00 հզր
190,00 հզր
851,00 հզր
1,22 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-22,38 մլն
-22,87 մլն
-18,82 մլն
-17,71 մլն
Gain or loss from assets sale
-
-
-
246,00 հզր
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps